Panbela Therapeutics, Inc.

MUN:X70 Stock Report

Market Cap: €2.4m

Panbela Therapeutics Management

Management criteria checks 3/4

Panbela Therapeutics' El consejero delegado es Jennifer Simpson , nombrado en Jul 2020, tiene un mandato de 3.67 años. la remuneración anual total es $571.92K , compuesta por 92.1% salario y 7.9% primas, incluidas acciones y opciones de la empresa. posee directamente 0% de las acciones de la empresa, por valor de €6.04 . La antigüedad media del equipo directivo y del consejo de administración es de 3.7 años y 4.3 años respectivamente.

Key information

Jennifer Simpson

Chief executive officer

US$571.9k

Total compensation

CEO salary percentage92.1%
CEO tenure3.8yrs
CEO ownership0.0001%
Management average tenure3.8yrs
Board average tenure4.3yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Jennifer Simpson's remuneration changed compared to Panbela Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$572kUS$527k

-US$34m

Sep 30 2023n/an/a

-US$24m

Jun 30 2023n/an/a

-US$20m

Mar 31 2023n/an/a

-US$36m

Dec 31 2022US$694kUS$506k

-US$35m

Sep 30 2022n/an/a

-US$34m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$12m

Dec 31 2021US$1mUS$477k

-US$10m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$5m

Dec 31 2020US$2mUS$146k

-US$5m

Compensación vs. Mercado: Jennifer($USD571.92K) está por encima de la media de empresas de tamaño similar en el mercado German ($USD394.82K).

Compensación vs. Ingresos: La compensación de Jennifer ha sido consistente con los resultados de la empresa en el último año.


CEO

Jennifer Simpson (55 yo)

3.8yrs

Tenure

US$571,921

Compensation

Dr. Jennifer K. Simpson, Ph.D. M.S.N. C.R.N.P. has been the Chief Executive Officer, President and Director of Panbela Therapeutics, Inc. (formerly known as Sun BioPharma, Inc.) since July 15, 2020. She se...


Leadership Team

NamePositionTenureCompensationOwnership
Jennifer Simpson
CEO, President & Director3.8yrsUS$571.92k0.00014%
$ 3.4
Susan Horvath
VP of Finance6yrsUS$467.92k0.00014%
$ 3.4
Tammy Groene
Vice President of Operationsno datano datano data
Elizabeth Bruckheimer
VP & Chief Scientific Officer1.8yrsno datano data

3.8yrs

Average Tenure

Equipo directivo experimentado: X70El equipo directivo de la empresa se considera experimentado (3.7 años de antigüedad media).


Board Members

NamePositionTenureCompensationOwnership
Jennifer Simpson
CEO, President & Director3.8yrsUS$571.92k0.00014%
$ 3.4
Jeffrey Mathiesen
Vice Chair & Lead Independent Director8.6yrsUS$85.14k0%
$ 0
Michael Cullen
Chairman8.6yrsUS$76.14k0.00045%
$ 11.0
Jeffrey Jacob
Director1.8yrsUS$43.63k0.000020%
$ 0.5
Daniel Donovan
Independent Director1.8yrsUS$56.13k0.00023%
$ 5.6
Arthur Fratamico
Independent Director4.3yrsUS$52.63k0%
$ 0
Donald Schemel
Independent Director8.6yrsUS$61.13k0.00045%
$ 11.0
Tanios Bekaii-Saab
Scientific Advisorno datano datano data
Andrew Ko
Scientific Advisorno datano datano data
Dusan Kotasek
Scientific Advisorno datano datano data

4.3yrs

Average Tenure

62yo

Average Age

Junta con experiencia: La junta directiva de X70 se considera experimentada (4.3 años de antigüedad promedio).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.